國立虎尾科技大學 |

Nuclear Medicine in Oncology = Molecular Imaging and Target Therapy /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Nuclear Medicine in Oncology/ edited by Gang Huang.
Reminder of title:	Molecular Imaging and Target Therapy /
other author:	Huang, Gang.
Description:	XI, 346 p. 247 illus., 157 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Oncology . -
Online resource:	https://doi.org/10.1007/978-981-13-7458-6
ISBN:	9789811374586

Nuclear Medicine in Oncology = Molecular Imaging and Target Therapy /
Nuclear Medicine in OncologyMolecular Imaging and Target Therapy /[electronic resource] :edited by Gang Huang. - 1st ed. 2019. - XI, 346 p. 247 illus., 157 illus. in color.online resource.

1. Glucose Metabolism Imaging -- 2. Clinical Utility of 18F-FDG PET/CT in Breast Cancer Management and Targeted Therapy -- 3. The application of 18F-FDG PET/CT in diagnose and therapy of non-small cell lung cancer -- 4. Clinical application of 18F-FDG PET/CT in lymphoma -- 5. Clinical utility of 18F-FDG PET/CT scanning in urological cancers management -- 6. Gynecologic tumor PET / CT imaging -- 7. Molecular imaging and targeted therapy of gastrointestinal cancer -- 8. Head and Neck Cancer -- 9. Molecular imaging and targeted therapy of malignant melanoma -- 10. Role of 18F-FDG PET/CT in Pediatric Oncology -- 11. Molecular imaging -- 12. Receptor targeted radionuclide imaging (RTRI) and peptide receptor radionuclide therapy (PRRT) -- 13. Radioimmunoimaging and targeted therapy -- 14. Apoptosis imaging -- 15. Radionuclide gene and reporter gene imaging -- 16. Na+/I− symporter target for thyroid disease imaging and treatment -- 17. Molecular Imaging and Targeted Therapy In Neurology -- 18. Nuclear cardiolgy -- 19. Equipment for imaging and mechanism, radiation protection -- 20. Molecular imaging probe.

This book introduces molecular imaging and Target Therapy in various cancers. The first part is the subjects and primary focused on the basics of nuclear physics, radiation dosimetry, nuclear medicine equipment and small animal imaging equipment. The second part is about the radiopharmaceutical and commonly used clinical radiopharmaceuticals, including positron emission imaging agent, single photon emission imaging agent, and radionuclide therapy agents as well as their radioactive preparation, quality control, and a brief clinical application were included. Also, this part introduces a number of new imaging agents which were potential value of clinical applications. In the third part, the clinical application of the conventional imaging agent 18F-FDG in different tumors and neurodegenerative diseases and 18F-Dopa imaging in the nervous system are discussed. Besides the clinical applications of 99mTc labeled radiopharmaceuticals in parathyroid disease, coronary heart disease, myocardial infarction, sentinel lymph node, metastatic bone tumors, liver and gallbladder disease in children are introduced. Finally, the applications of radionuclide 131I on treatments of Graves' disease and differentiated thyroid cancer and metastases are investigated respectively. This book is a useful reference for professionals engaged in nuclear medicine and clinical research, including clinical nuclear medicine physicians, nuclear medicine engineers and nuclear medicine pharmacists.

ISBN: 9789811374586

Standard No.: 10.1007/978-981-13-7458-6doiSubjects--Topical Terms:

1253469
Oncology .

LC Class. No.: RC254-282

Dewey Class. No.: 616.994

Nuclear Medicine in Oncology = Molecular Imaging and Target Therapy /
LDR:03943nam a22003975i 4500 001 1011469
003 DE-He213
005 20200706234548.0
007 cr nn 008mamaa
008 210106s2019 si | s |||| 0|eng d
020 $a 9789811374586 $9 978-981-13-7458-6
024 7 $a 10.1007/978-981-13-7458-6 $2 doi
035 $a 978-981-13-7458-6
050 4 $a RC254-282
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.994 $2 23
245 1 0 $a Nuclear Medicine in Oncology $h [electronic resource] : $b Molecular Imaging and Target Therapy / $c edited by Gang Huang.
250 $a 1st ed. 2019.
264 1 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2019.
300 $a XI, 346 p. 247 illus., 157 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a 1. Glucose Metabolism Imaging -- 2. Clinical Utility of 18F-FDG PET/CT in Breast Cancer Management and Targeted Therapy -- 3. The application of 18F-FDG PET/CT in diagnose and therapy of non-small cell lung cancer -- 4. Clinical application of 18F-FDG PET/CT in lymphoma -- 5. Clinical utility of 18F-FDG PET/CT scanning in urological cancers management -- 6. Gynecologic tumor PET / CT imaging -- 7. Molecular imaging and targeted therapy of gastrointestinal cancer -- 8. Head and Neck Cancer -- 9. Molecular imaging and targeted therapy of malignant melanoma -- 10. Role of 18F-FDG PET/CT in Pediatric Oncology -- 11. Molecular imaging -- 12. Receptor targeted radionuclide imaging (RTRI) and peptide receptor radionuclide therapy (PRRT) -- 13. Radioimmunoimaging and targeted therapy -- 14. Apoptosis imaging -- 15. Radionuclide gene and reporter gene imaging -- 16. Na+/I− symporter target for thyroid disease imaging and treatment -- 17. Molecular Imaging and Targeted Therapy In Neurology -- 18. Nuclear cardiolgy -- 19. Equipment for imaging and mechanism, radiation protection -- 20. Molecular imaging probe.
520 $a This book introduces molecular imaging and Target Therapy in various cancers. The first part is the subjects and primary focused on the basics of nuclear physics, radiation dosimetry, nuclear medicine equipment and small animal imaging equipment. The second part is about the radiopharmaceutical and commonly used clinical radiopharmaceuticals, including positron emission imaging agent, single photon emission imaging agent, and radionuclide therapy agents as well as their radioactive preparation, quality control, and a brief clinical application were included. Also, this part introduces a number of new imaging agents which were potential value of clinical applications. In the third part, the clinical application of the conventional imaging agent 18F-FDG in different tumors and neurodegenerative diseases and 18F-Dopa imaging in the nervous system are discussed. Besides the clinical applications of 99mTc labeled radiopharmaceuticals in parathyroid disease, coronary heart disease, myocardial infarction, sentinel lymph node, metastatic bone tumors, liver and gallbladder disease in children are introduced. Finally, the applications of radionuclide 131I on treatments of Graves' disease and differentiated thyroid cancer and metastases are investigated respectively. This book is a useful reference for professionals engaged in nuclear medicine and clinical research, including clinical nuclear medicine physicians, nuclear medicine engineers and nuclear medicine pharmacists.
650 0 $a Oncology . $3 1253469
650 0 $a Nuclear medicine. $3 673902
650 0 $a Interventional radiology . $3 1254011
650 1 4 $a Oncology. $3 593951
650 2 4 $a Nuclear Medicine. $3 673045
650 2 4 $a Interventional Radiology. $3 673687
700 1 $a Huang, Gang. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1140566
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9789811374579
776 0 8 $i Printed edition: $z 9789811374593
776 0 8 $i Printed edition: $z 9789811374609
856 4 0 $u https://doi.org/10.1007/978-981-13-7458-6
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)